Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Ryan, P; Dolengevich-Segal, H; Ramos-Ruperto, L; Cabello, A; Sanchez-Conde, M; Vergas, J; Valencia, J; Cuevas, G; Sanz, J; Curto-Ramos, J; Perez-Bootello, J; Naharro-Rodriguez, J; Ollero, MJF; Fraile, LG; Perez-Latorre, L; Bisbal, O; de la Fuente, S; Losa, JE; Cervero, M; Estebanez, M; Suarez-Garcia, I; Gimeno, A; Terrancle, I; Mican, R; Gonzalez-Baeza, A.

Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study-The U-SEX-2 GESIDA 9416 Study

Journal of Clinical Medicine. 2023; 12(23): Nº de citas: 7 [doi:10.3390/jcm12237293]

Suárez-García, I; Gutierrez, F; Pérez-Molina, JA; Moreno, S; Aldamiz, T; Ortega, EV; Curran, A; González, SG; Asensi, V; Prous, CA; Jarrin, I; Rava, M.

Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; 149(20): 18161-18171 Nº de citas: 6 [doi:10.1007/s00432-023-05500-9]

Martín-Escolano, R; Vidal-Alcántara, EJ; Crespo, J; Ryan, P; Real, LM; Lazo-Alvarez, JI; Cabezas-González, J; Macías, J; Arias-Loste, MT; Cuevas, G; Virseda-Berdices, A; Briz, V; Resino, S; Jiménez-Sousa, MA; Fernández-Rodriguez, A.

Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk

Immunity & Ageing. 2023; 20(1): Nº de citas: 4 [doi:10.1186/s12979-023-00387-z]

Alvarez, H; Gutiérrez-Valencia, A; Mariño, A; Saborido-Alconchel, A; Calderón-Cruz, B; Pérez-González, A; Alonso-Domínguez, J; Martínez-Barros, I; Gallego-Rodríguez, M; Moreno, S; Aldamiz, T; Montero-Alonso, M; Bernal, E; Galera, C; Llibre, JM; Poveda, E; CoRIS Study Grp.

IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors

Frontiers in Immunology. 2023; 14: Nº de citas: 5 [doi:10.3389/fimmu.2023.1257725]

de Mendoza C; Rando A; Miró E; Pena MJ; Rodríguez-Avial I; Ortega D; González-Praetorius A; Reina G; Pintos I; Pozuelo MJ; Soriano V.

Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions.

JOURNAL OF CLINICAL VIROLOGY. 2023; 167: 105578-105578 Nº de citas: 5 [doi:10.1016/j.jcv.2023.105578]

Podzamczer, D; Imaz, A; Lopez-Lirola, A; Knobel, H; Masiá, M; Fanciulli, C; Hernández, C; Lagarde, M; Gutierrez, A; Curran, A; Morano, L; Montero-Alonso, M; Troya, J; Rigo, R; Casadellà, M; Navarro-Alcaraz, A; Ardila, F; Parera, M; Bernal, E; Echeverria, P; Estrada, V; Hidalgo-Tenorio, C; Macias, J; Prieto, P; Portilla, J; Valencia, E; Vivancos, MJ; Rivero, A.

Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(11): 2696-2701 Nº de citas: 4 [doi:10.1093/jac/dkad285]

Bouza, E; Guillen-Zabala, H; Rojas, A; Canada, G; Cercenado, E; Sanchez-Carrillo, C; Martin-Rabadan, P; Diez, C; Puente, L; Munoz, P; Galar, A.

Comparative study of the etiology of nosocomial bacteremic pneumonia in ventilated and non-ventilated patients: a 10-year experience in an institution

Microbiology spectrum. 2023; 11: Nº de citas: 3 [doi:10.1128/spectrum.01517-23]

Vicente-Valor, J; Rodriguez-Gonzalez, C; Ferris-Villanueva, M; Chamorro-de-Vega, E; Romero-Jimenez, R; Gomez-Costas, D; Herrero-Bermejo, S; Tejerina-Picado, F; Osorio-Prendes, S; Oarbeascoa-Royuela, G; Herranz-Alonso, A; Sanjurjo-Saez, M.

Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study

PHARMACOLOGICAL REPORTS. 2023; 75(5): 1254-1264 Nº de citas: 1 [doi:10.1007/s43440-023-00519-8]

Vizcarra, P; Moreno, A; Vivancos, MJ; García, AM; Schacke, MR; González-Garcia, J; Curran, A; Palacios, R; Guirao, AJS; Bañuls, SR; Guillén, SM; Casado, JL; Spanish HIV Res Network CoRIS.

A Risk Assessment Tool for Predicting Fragility Fractures in People with HIV: Derivation and Internal Validation of the FRESIA Model

JOURNAL OF BONE AND MINERAL RESEARCH. 2023; 38(10): 1443-1452 Nº de citas: 4 [doi:10.1002/jbmr.4894]

Sanchez-Conde, M; Alba, C; Castro, I; Dronda, F; Ramirez, M; Arroyo, R; Moreno, S; Rodriguez, JM; Branas, F.

Comparison of the Fecal Bacteriome of HIV-Positive and HIV-Negative Older Adults

Biomedicines. 2023; 11(8): Nº de citas: 3 [doi:10.3390/biomedicines11082305]

Martin-Escolano, R; Virseda-Berdices, A; Berenguer, J; Gonzalez-Garcia, J; Brochado-Kith, O; Fernandez-Rodriguez, A; Diez, C; Hontanon, V; Resino, S; Jimenez-Sousa, MA.

Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patients

BIOMEDICINE & PHARMACOTHERAPY. 2023; 164: Nº de citas: 4 [doi:10.1016/j.biopha.2023.114913]

Candel, FJ; Barreiro, P; Salavert, M; Cabello, A; Fernández-Ruiz, M; Pérez-Segura, P; San Román, J; Berenguer, J; Córdoba, R; Delgado, R; España, PP; Gómez-Centurión, IA; del Castillo, JMG; Heili, SB; Martínez-Peromingo, FJ; Menéndez, R; Moreno, S; Pablos, JL; Pasquau, J; Piñana, JL; MODUS Investigators Adenda.

Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

Viruses-Basel. 2023; 15(7): Nº de citas: 10 [doi:10.3390/v15071449]

Trickey, A; Ingle, SM; Boyd, A; Gill, MJ; Grabar, S; Jarrin, I; Obel, N; Touloumi, G; Zangerle, R; Rauch, A; Rentsch, CT; Satre, DD; Silverberg, MJ; Bonnet, F; Guest, J; Burkholder, G; Crane, H; Teira, R; Berenguer, J; Wyen, C; Abgrall, S; Hessamfar, M; Reiss, P; Monforte, AD; McGinnis, KA; Sterne, JAC; Wittkop, L.

Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies

JOURNAL OF VIRAL HEPATITIS. 2023; 30(9): 775-786 Nº de citas: 1 [doi:10.1111/jvh.13863]

Palomino-Cabrera, R; Tejerina, F; Molero-Salinas, A; Ferris, M; Veintimilla, C; Catalan, P; Macias, GR; Alonso, R; Munoz, P; de Viedma, DG; Perez-Lago, L.

Frequent Emergence of Resistance Mutations Following Complex Intra-Host Genomic Dynamics in SARS-CoV-2 Patients Receiving Sotrovimab

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2023; 67(7): Nº de citas: 6 [doi:10.1128/aac.00266-23]

Ruiz-Alguero, M; Izquierdo, R; Suarez-Garcia, I; Moreno, C; Alejos, B; Rava, M; Moreno, S; Alonso, MM; Gutierrez, F; Cuellar, IG; Curran, A; Hernando, V; Jarrin, I.

Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV

HIV MEDICINE. 2023; 24(6): 727-737 Nº de citas: 2 [doi:10.1111/hiv.13469]

Alonso-Navarro, R; Ramirez, M; Masia, M; Paredes, R; Montejano, R; Povar-Echeverria, M; Carratala, J; Salavert, M; Bernal, E; Duenas, C; Flores, J; Fanjul, F; Gutierrez, I; Rico, V; Mateu, L; Cadinanos, J; Berenguer, J; Soriano, A.

Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses

BMC INFECTIOUS DISEASES. 2023; 23(1): Nº de citas: 8 [doi:10.1186/s12879-023-08222-y]

Sepulveda-Crespo, D; Trevino-Nakoura, A; Bellon, JM; Fernandez-Rodriguez, A; Ryan, P; Martinez, I; Jimenez-Sousa, MA; Resino, S.

Diagnostic performance of hepatitis C core antigen assay to identify active infections: A systematic review and meta-analysis

REVIEWS IN MEDICAL VIROLOGY. 2023; 33(3): Nº de citas: 7 [doi:10.1002/rmv.2436]

Palacios, R; Gomez-Ayerbe, C; Casado, JL; Tejerina, F; Montes, ML; Castano, M; Ocampo, A; Rial, D; Ribera, E; Galindo, MJ; Hidalgo, C; Farinas, C; Montero, M; Payeras, T; Fanjul, F; de la Torre, J; Santos, J.

Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119

HIV MEDICINE. 2023; 24(8): 933-937 Nº de citas: 4 [doi:10.1111/hiv.13489]